StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Raised to $90 at RBC Capital
July 26, 2018 7:58 AM
RBC Capital raised its price target on Gilead Sciences (NASDAQ: GILD) to $90.00 (from $87.00) while maintaining an Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Gilead Sciences (GILD) PT Raised to $85 at Morgan Stanley
July 26, 2018 8:53 AM
Gilead Sciences (GILD): HIV Outpaces HCV Decline, PT To $95 - Wells Fargo
July 26, 2018 6:35 AM
Baird Downgrades Gilead Sciences (GILD) to Neutral
July 26, 2018 5:32 AM
Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 2.9% Yield
July 25, 2018 6:37 PM
Form 8-K GILEAD SCIENCES INC For: Jul 25
July 25, 2018 4:05 PM
Gilead Sciences (GILD) Tops Q2 EPS by 35c
July 25, 2018 4:02 PM
Gilead Sciences Announces Third Quarter 2018 Dividend
July 25, 2018 4:02 PM
Gilead Sciences Announces Second Quarter 2018 Financial Results
July 25, 2018 4:01 PM
